OmniComm Systems(R) Acquires IRT Technology From ClinQuest
TrialMaster(R) EDC Suite and IRTMaster(TM) Integrated for Faster Study Start-Up and Site Optimization
OmniComm Systems(R) Announces 141% YOY Growth in Total Contract Value
World–s Largest CROs and Pharmaceutical Companies Comprise 33% of Total Contract Value
OmniComm Systems(R) Recognizes Excellence in Clinical Research and Development at Innovation Forum 2014
Industry Leaders Convene to Demonstrate the Transformative Effect of OmniComm Technology
OmniComm Systems(R) Announces 135% YOY Growth in Total Contract Value Through Q3 2014
FORT LAUDERDALE, FL — (Marketwired) — 11/26/14 — OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced that Q3 2014 total contract value was up by over 260% from the same period in 2013. Year-over-year total contract value grew over 135%. New clients accounted for over 73% of all new contracts through Q3 2014 and 20% of all contracts had a term life in excess of 30 months. The record contract growth is attributed t
Larix, Denmark–s Full Service Contract Research Organization, Selects OmniComm–s(R) TrialMaster(R) Electronic Data Capture Solution
FORT LAUDERDALE, FL — (Marketwired) — 11/20/14 — OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to announce that Larix; a full service Danish contract research organization (CRO) offering statistics, data management and medical writing, has selected TrialMaster electronic data capture (EDC) as its standard EDC technology. Located in the heart of the Denmark–s Medicon Valley, one of Europe–s preeminent centers f
Omicia Introduces Phevor to Boost Identification of Disease-Causing Gene Mutations
OAKLAND, CA — (Marketwired) — 10/28/14 — Omicia, Inc., , today announced it is integrating Phevor (Phenotype Driven Variant Ontological Re-ranking tool) into its Opal product offering. Phevor, an algorithm co-developed by the University of Utah and Omicia, accelerates identification of disease-relevant variants in genomic sequences.Phevor is being integrated into Omicia–s Opal platform including with , a comprehensive Software-as-a-Service genomic interpretation platform that was introduced
Belgian Contract Research Organization, Business & Decision Life Sciences, Partners With OmniComm Systems(R)
OmniComm Systems CRO Preferred Program Enables Faster, More Efficient Studies for Business & Decision Life Sciences– Customers
Top 10 Pharmaceutical Company Moves to OmniComm Systems–(R) OmniCloud(R)
Company Migrates On-Premise Clinical Data Management Technology to OmniCloud Hosted Environment
MMRGlobal to Report Third Quarter Revenue Exceeding Biggest Year in Company History
LOS ANGELES, CA — (Marketwired) — 10/06/14 — (OTCQB: MMRF) ("MMR" or the "Company") today announced that it will report third quarter revenues from all sources in excess of total revenues from its biggest year. The Health Information Technology and Biotechnology Company will report substantially more revenue than the $1.420 million reported from the entire calendar year of 2011, previously the biggest year in the Company–s history and which the Company has received in c
MMRGlobal Receives Significant Intellectual Property Milestone Payment
LOS ANGELES, CA — (Marketwired) — 09/17/14 — (OTCQB: MMRF) ("MMR" or the "Company") today announced that it has received another significant milestone payment pursuant to an existing Non-Exclusive License Agreement (the "Agreement") pertaining to the Company–s biotech assets. Additional information regarding this milestone payment will be contained in the Company–s quarterly report on Form 10-Q for the quarter ending September 30, 2014. The non-exclusive Agre